These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15765018)

  • 21. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.
    Chen R; Tilley MR; Wei H; Zhou F; Zhou FM; Ching S; Quan N; Stephens RL; Hill ER; Nottoli T; Han DD; Gu HH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9333-8. PubMed ID: 16754872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
    Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
    Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.
    Calipari ES; Ferris MJ; Salahpour A; Caron MG; Jones SR
    Nat Commun; 2013; 4():2720. PubMed ID: 24193139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].
    Jaber M; Bloch B; Caron MG; Giros B
    C R Seances Soc Biol Fil; 1998; 192(6):1127-37. PubMed ID: 10101608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.
    Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
    J Biol Chem; 2006 Oct; 281(43):32072-80. PubMed ID: 16954211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
    Schmitt KC; Reith ME
    Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
    Kasahara Y; Kubo Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):185-9. PubMed ID: 25069256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice.
    Thanos PK; Michaelides M; Benveniste H; Wang GJ; Volkow ND
    Synapse; 2008 May; 62(5):319-24. PubMed ID: 18286542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders.
    Gowrishankar R; Hahn MK; Blakely RD
    Neurochem Int; 2014 Jul; 73():42-8. PubMed ID: 24231471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
    Zhao G; Li S; Qin GW; Fei J; Guo LH
    J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice.
    Carpenter AC; Saborido TP; Stanwood GD
    Dev Neurosci; 2012; 34(2-3):250-7. PubMed ID: 22572477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
    Herborg F; Andreassen TF; Berlin F; Loland CJ; Gether U
    J Biol Chem; 2018 May; 293(19):7250-7262. PubMed ID: 29559554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengths and limitations of genetic models of ADHD.
    Gainetdinov RR
    Atten Defic Hyperact Disord; 2010 Mar; 2(1):21-30. PubMed ID: 21432587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system.
    Adinolfi A; Zelli S; Leo D; Carbone C; Mus L; Illiano P; Alleva E; Gainetdinov RR; Adriani W
    Behav Brain Res; 2019 Feb; 359():516-527. PubMed ID: 30472113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single Quantum Dot Imaging Reveals PKCĪ²-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.
    Thal LB; Tomlinson ID; Quinlan MA; Kovtun O; Blakely RD; Rosenthal SJ
    ACS Chem Neurosci; 2019 Jan; 10(1):460-471. PubMed ID: 30153408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of mu-opioid receptor knockout mice.
    Mathon DS; Vanderschuren LJ; Ramakers GM
    Neuroscience; 2006 Sep; 141(4):1679-84. PubMed ID: 16777349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse.
    Zhu J; Reith ME
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):393-409. PubMed ID: 19128199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.